Login / Signup
Phase Ib study of the mTOR inhibitor everolimus with low dose cytarabine in elderly acute myeloid leukemia.
Ing Soo Tiong
Peter Tan
Julie McManus
Nik Cummings
Sonali Sadawarte
John Catalano
Robert Hills
Andrew H Wei
Published in:
Leukemia & lymphoma (2017)
Keyphrases
</>
acute myeloid leukemia
low dose
high dose
allogeneic hematopoietic stem cell transplantation
cell proliferation
middle aged